The practice
Independent advisory for life-sciences market access.
A Moscow-based independent consulting practice, active since 2019, supporting pharmaceutical and medical-device companies on commercial strategy, regulatory documentation, pharmacoeconomic evidence and market access across Russia and the EAEU.
Every recommendation is framed in evidence a payer or regulator can act on — with international research channels (including Singapore / ASEAN) available where a question reaches beyond the region.
At a glance
Scope
Pharmaceuticals & medical devices
Geography
Russia / EAEU · international channels
Active since
2019 · independent practice
Based in
Moscow, Russian Federation
Legal status
Sole proprietor (ИП) · ОГРНИП 319774600252261
Services
How we support market access.
A focused set of services for entering and operating in the Russian and EAEU life-sciences market. Exact scope and deliverables are agreed with each client.
Regulatory & market-access advisory — pharma
RU / EAEU registration pathways, reimbursement listing (ЖНВЛП) and localisation requirements for pharmaceutical products.
Medical-device registration & compliance
Roszdravnadzor and EAEU device pathways — technical files, conformity, and post-market vigilance documentation.
Pharmacoeconomics & HTA support
Cost-effectiveness and budget-impact analysis, value dossiers and evidence packages for reimbursement and formulary decisions.
Regulatory documentation & translation
Dossier support (including eCTD-aligned structure) and technical / medical RU ↔ EN translation and document preparation.
Russian market support
Supplier and CMO identification, contract-manufacturing localisation, and documentation updates to current RU / EAEU requirements.
Market research & financial modelling
Market sizing, forecasting, pricing scenarios and decision-ready business cases — segment analysis of the pharma market.
Public affairs & stakeholder engagement
Compliant liaison with industry associations and regulatory bodies; international research channels (incl. Singapore) on request.
Digital analytics at the IT × healthcare intersection
Interactive dashboards and automated pipelines for collecting and processing data — tenders / ЕИС, customs statistics, open registries — plus predictive models of access and demand. International research channels (incl. Singapore / ASEAN) engaged where needed.
Second track
The same toolkit, beyond life sciences.
Pharma market access is the practice's headline work — and it rests on a broader base: financial modelling, software delivery and data engineering for clients across industries.
Financial modelling & analysis
Models for investment programmes and venture portfolios, pricing and unit economics — decision-ready business cases, Excel/VBA automation, dashboards.
Software & app engineering consultancy
Full-cycle IT delivery from idea and backlog to production — product & project management, Agile at scale, pre-sale support and rapid prototyping.
Data & analytics engineering
Automated pipelines, interactive dashboards and forecasting models — the common technical thread across both tracks of the practice.
Method
Every recommendation framed in evidence.
Three principles run through the work — from the first data pull to the final dossier.
Evidence & pharmacoeconomics
Market data, forecasting, cost-effectiveness and budget-impact modelling — decision-ready business cases in numbers a payer can act on.
Regulatory & documentation
Accurate, audit-ready dossiers for pharmaceuticals and technical files for devices — with translation and localisation aligned to RU / EAEU requirements.
Access & engagement
Compliant stakeholder engagement built on transparent, association-led channels — and international research where a question needs it.
The toolkit behind the analytics.
A working constellation of the regulatory frameworks, evidence methods and data sources the practice moves between — the vocabulary of market access, rendered live.
Track record
Delivered in Russia, connected internationally.
Representative engagements across regulatory documentation, sourcing, analytics and international research.
Pharma localisation & dossier advisory
Advised Russian pharmaceutical clients on registration dossiers, contract-manufacturing localisation, and documentation updates to current RU / EAEU requirements.
Sourcing & market support
Supplier and partner identification in pharma manufacturing, with support for customers updating product documentation and navigating EAEU procedures.
Contract research coordination
Coordinated contract research with international partners across Southeast Asia, including engagement with a national research agency and a national innovation programme.
Market analytics & forecasting
Segment sizing and demand scenarios for the pharma market, built on automated data pipelines (tenders / ЕИС, customs statistics, registries) and interactive dashboards.
Let's talk
Discuss your market-access needs.
Registration, dossiers, HTA evidence, market analytics, or documentation that has to hold up under review — I'm easy to reach.